Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague

被引:63
作者
Elvin, SJ [1 ]
Williamson, ED [1 ]
机构
[1] Def Sci & Technol Labs, Salisbury SP4 0JQ, Wilts, England
关键词
plague; protection; Stat; 4; 6; sub-unit;
D O I
10.1016/j.micpath.2004.06.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Caf1 and LcrV sub-unit vaccine for plague has been shown to be highly protective against challenge with virulent Yersinia pestis in a mouse model. Production of large amounts of IgG1 in response to the vaccine correlates with protection against aerosol and parenteral infection. In this study the effect of genetic mutation in the immune system on protection was addressed. Stat 6(-/-) mice which are unable to utilise the type 2 cytokines IL-4 and IL-13 and so should have reduced IgG1 responses were utilised in order to determine whether an immune system biased towards the type 1 axis could mount an effective response to the vaccine. Conversely in the Stat 4(-/-) mouse model, IL-12 and interferon-gamma-mediated immune mechanisms are inactive and the immune response should be biased towards the type 2 axis. Serum antibody responses to vaccination in both the knockout strains and their wild type controls revealed little difference in levels of IgG and isotype profiles. Elispot analysis of cytokine production at the single cell level did however reveal a functional defect in the Stat 4(-/-) mice which had low levels of IFN-gamma producing cells. Following virulent challenge, the Stat 6(-/-) mice showed high levels of protection, while the Stat 4(-/-) mice were poorly protected, indicating a fundamental defect in their immune systems which could not be overcome even by the passive transfer of CD4(+) cells from immunised BALB/c donors. It appears therefore that type 1 immune mechanisms, activated following Stat 4 phosphorylation, are essential in protection against plague. Crown Copyright (C) 2004 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 49 条
[21]   ACTIVE IMMUNIZATION WITH RECOMBINANT V-ANTIGEN FROM YERSINIA-PESTIS PROTECTS MICE AGAINST PLAGUE [J].
LEARY, SEC ;
WILLIAMSON, ED ;
GRIFFIN, KF ;
RUSSELL, P ;
ELEY, SM ;
TITBALL, RW .
INFECTION AND IMMUNITY, 1995, 63 (08) :2854-2858
[22]   PLAGUE IMMUNIZATION .2. RELATION OF ADVERSE CLINICAL REACTIONS TO MULTIPLE IMMUNIZATIONS WITH KILLED VACCINE [J].
MARSHALL, JD ;
BARTELLONI, PJ ;
CAVANAUGH, DC ;
KADULL, PJ ;
MEYER, KF .
JOURNAL OF INFECTIOUS DISEASES, 1974, 129 :S19-S25
[23]  
MEYER KF, 1970, B WORLD HEALTH ORGAN, V42, P653
[24]  
Miller J, 1998, FEMS IMMUNOL MED MIC, V21, P213, DOI 10.1111/j.1574-695X.1998.tb01168.x
[25]   The expanding universe of T-cell subsets: Th1, Th2 and more [J].
Mosmann, TR ;
Sad, S .
IMMUNOLOGY TODAY, 1996, 17 (03) :138-146
[26]  
MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.iy.07.040189.001045
[27]   SUPPRESSION OF CYTOKINES IN MICE BY PROTEIN A-V ANTIGEN FUSION PEPTIDE AND RESTORATION OF SYNTHESIS BY ACTIVE IMMUNIZATION [J].
NAKAJIMA, R ;
MOTIN, VL ;
BRUBAKER, RR .
INFECTION AND IMMUNITY, 1995, 63 (08) :3021-3029
[28]   ASSOCIATION BETWEEN VIRULENCE OF YERSINIA-PESTIS AND SUPPRESSION OF GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR-ALPHA [J].
NAKAJIMA, R ;
BRUBAKER, RR .
INFECTION AND IMMUNITY, 1993, 61 (01) :23-31
[29]   Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: Amplification of interleukin-10 [J].
Nedialkov, YA ;
Motin, VL ;
Brubaker, RR .
INFECTION AND IMMUNITY, 1997, 65 (04) :1196-1203
[30]   The IL-4 receptor: Signaling mechanisms and biologic functions [J].
Nelms, K ;
Keegan, AD ;
Zamorano, J ;
Ryan, JJ ;
Paul, WE .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :701-738